Casey Grillo
Family · New York, NYNPI 1801135942
Payments from drug & device makers
Across 923 payments — averaging $206.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$153K
- Nalu Medical, Inc.$25K
- Boston Scientific$2K
- Painteq LLC$2K
- Spinal Simplicity, LLC$1K
- Biohaven Pharmaceuticals, Inc.$918
- plus $7K from 28 others
What the payments were for
- Consulting fees$23,24712%
- Speaking & faculty fees$86,69445%
- Travel & lodging$55,32929%
- Food & beverage$25,24313%
- Education$5360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 630 | $153,307 |
| Nalu Medical, Inc. | 75 | $25,218 |
| Boston Scientific | 19 | $1,898 |
| Painteq LLC | 11 | $1,697 |
| Spinal Simplicity, LLC | 12 | $1,171 |
| Biohaven Pharmaceuticals, Inc. | 8 | $918 |
| Vertos Medical, Inc. | 10 | $783 |
| Stryker | 3 | $771 |
| Foundation Fusion Solutions, LLC | 7 | $729 |
| Collegium Pharmaceutical, Inc. | 31 | $553 |
| Relievant Medsystems, Inc. | 3 | $451 |
| Biotronik NRO, Inc. | 3 | $419 |
| Medtronic | 8 | $407 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $386 |
| Saluda Medical Americas, Inc. | 7 | $351 |
| Kowa Pharmaceuticals America, Inc. | 13 | $318 |
| Forte Bio-pharma LLC | 11 | $272 |
| Pfizer | 10 | $215 |
| SPR Therapeutics, Inc | 3 | $192 |
| MML US, Inc. | 1 | $157 |
| Scilex Pharmaceuticals Inc. | 6 | $138 |
| Stimwave Technologies Incorporated | 1 | $117 |
| Vertex | 5 | $104 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $84 |
| Almatica Pharma LLC | 4 | $83 |
| Valinor Pharma, LLC | 3 | $57 |
| GRT US Holding, Inc. | 3 | $50 |
| Si-bone, Inc. | 1 | $48 |
| Averitas Pharma Inc. | 2 | $46 |
| Biodelivery Sciences International, Inc. | 2 | $34 |
| AbbVie | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$122,081
- Nalu Neurostimulation System$23,922
- Proclaim IPG$10,199
- Axium$4,843
- PAINTEQ$1,438
- mild Device Kit$1,295
- Intracept$1,233
- WaveWriter Alpha Prime 16$1,061
- Axium Sheath Braided DRG$1,061
- ETERNA$915
- IonicRF Generator$813
- NURTEC ODT$800
- Proclaim DRG IPG$781
- HA MINUTEMAN G3-R$780
- Axium INS DRG IPG$686
- Prospera$419
- Evoke SCS$230
- FreeStyle Precision Pro system$223
- INTELLIS ADAPTIVESTIM$174
- ReActiv8$157
How this compares
$191,049 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 16 | $13,683 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 373 | $8,478 |
| Buprenorphine | 23 | $5,280 |
| Lidocaine | 37 | $4,522 |
| Diclofenac Sodium | 57 | $3,808 |
| Pregabalin | 111 | $3,339 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 117 | $2,323 |
| Gabapentin | 133 | $1,439 |
| Fentanyl | 14 | $1,302 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 50 | $997 |
| Tramadol Hcl | 150 | $976 |
| Tramadol Hcl ErTramadol Hcl | 13 | $703 |
| Tizanidine Hcl | 105 | $664 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $614 |
| Cyclobenzaprine Hcl | 76 | $577 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $553 | $13,68316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in New York
- Christina NalboneNew York$197K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
- Margaret CuomoNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.